CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in DSGN — Design Therapeutics, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in DSGN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,569,400
+$347,626 QoQ
Shares Held
241,485
+2.0% QoQ
Ownership
0.387%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DSGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $6,185,699,337 across 288 Biotechnology names. DSGN ranks #165 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,920,871 | $857,745,736 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
804,508 | $621,595,061 | |
| 3 | MRNA |
Moderna, Inc.
|
4,734,356 | $240,505,284 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
673,356 | $222,793,299 | |
| 5 | INSM |
INSMED Inc
|
1,069,390 | $174,866,652 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
1,735,476 | $168,775,041 | |
| 7 | INCY |
Incyte Corp
|
1,729,102 | $162,743,080 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,976,094 | $146,744,740 |
All Filings in DSGN
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,569,400 | 241,485 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,221,774 | 236,863 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,866,943 | 247,934 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $845,698 | 250,949 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $997,327 | 258,375 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $1,633,044 | 264,675 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $1,384,984 | 257,432 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $602,866 | 179,960 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $722,055 | 179,170 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $465,459 | 175,645 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $409,566 | 173,545 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $1,441,477 | 228,806 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $1,329,102 | 230,347 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $2,369,157 | 230,912 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $3,754,643 | 224,560 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,886,850 | 134,775 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,976,243 | 122,368 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $2,538,283 | 118,556 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $1,329,753 | 90,521 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $1,745,645 | 87,765 | Shares | Sole | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||